Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
LATEST NEWS
As the FDA Takes Center Stage During COVID, Big Changes Could Be Ahead
By Adam Smith
41 minutes ago
INVESTING
Jim Cramer: What History Tells Us About Bond-Rate Scares Like This
By Jim Cramer
1 hour ago
LATEST NEWS
Quickly Vaccinating Hong Kong May Be a Long Shot
By Adam Smith
30 minutes ago
INVESTING
Johnson & Johnson's COVID-19 Vaccine Is Cleared by the FDA
By Joseph Woelfel
20 hours ago
INVESTING
Johnson & Johnson One-Shot Vaccine Wins Advisory Panel OK
By Tom Bemis
Feb 26, 2021 5:59 PM EST
INVESTING
J&J Vaccine May Be Near OK, With Shots to Follow Soon After
By Dan Weil
Feb 26, 2021 10:14 AM EST
INVESTING
Moderna Extends Gains as Jim Cramer Talks About Potential Cancer Vaccine
By Martin Baccardax
Feb 26, 2021 9:45 AM EST
PRESS RELEASES
European Medicines Agency Accepts Pfizer's Marketing Authorization Application For Its Investigational 20-valent Pneumococcal Conjugate Vaccine For Adults 18 Years Of Age Or Older
By Business Wire
Feb 26, 2021 6:45 AM EST
PRESS RELEASES
EMA Accepts Marketing Application For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency
By Business Wire
Feb 26, 2021 6:30 AM EST
Video
Moderna Says Trials for COVID Variant Boost Shot Have Begun
Feb 25, 2021 11:16 AM EST
INVESTING
Moderna Fourth-Quarter Sales Boosted by COVID Vaccine Rollout
By M. Corey Goldman
Feb 25, 2021 11:17 AM EST
PRESS RELEASES
Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants
By GlobeNewswire
Feb 25, 2021 6:45 AM EST
PRESS RELEASES
Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants
By Business Wire
Feb 25, 2021 6:45 AM EST
MARKETS
Nvidia, GameStop, AMC, Salesforce, Pfizer - 5 Things You Must Know Thursday
By Joseph Woelfel
Feb 25, 2021 8:51 AM EST
INVESTING
Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing
By Martin Baccardax
Feb 24, 2021 9:33 AM EST
PRESS RELEASES
Seven Bridges Selected By Pfizer To Support Data Management Solution For Single-Cell RNA Sequencing Data
By PR Newswire
Feb 24, 2021 8:00 AM EST
PRESS RELEASES
U.S. FDA Accepts For Priority Review Pfizer's Application For TicoVac™ (Tick-borne Encephalitis Vaccine)
By Business Wire
Feb 23, 2021 4:30 PM EST
INVESTING
Johnson & Johnson Will Deliver 20 Million Vaccine Doses to the U.S. By End of March
By Tony Owusu
Feb 24, 2021 9:08 AM EST
MARKETS
Stocks End Mixed, Nasdaq Sinks as Higher Yields Weigh on Tech
By Joseph Woelfel
Feb 22, 2021 4:17 PM EST
INVESTING
Viatris Slumps as JPMorgan Comments on Weak EBITDA Forecast
By Tony Owusu
Feb 22, 2021 3:54 PM EST
PRESS RELEASES
Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference
By Business Wire
Feb 22, 2021 10:00 AM EST
INVESTING
GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials
By Martin Baccardax
Feb 22, 2021 6:52 AM EST
INVESTING
Dow Futures Slide on Inflation Concerns, Boeing 777 Suspension
By Martin Baccardax
Feb 22, 2021 9:25 AM EST
LATEST NEWS
Giving Pfizer a Shot: Virologist Gives His Take on the Jab in Japan
By Adam Smith
Feb 21, 2021 6:15 PM EST
LATEST NEWS
COVID on Track to Kill a Half Million Americans
By Adam Smith
Feb 21, 2021 6:03 PM EST